Study of iHD-SRT for brain metastases
Part of Brain & nervous system, Cancer clinical trials.
This study tests a new type of radiation therapy (iHD-SRT) for people with brain metastases. It aims to see if this approach is safe and effective for treating tumors that have spread to the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer that has spread to the brain
- You have 15 or fewer brain tumors, and the total volume of these tumors is 20 cc or less
- Your brain tumors are in a location that can be treated with this specialized radiation technique
- You are able to take care of yourself (ECOG performance status 0 to 2)
- Your expected survival is at least 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with a small number of brain metastases who are treated with a focused, staged form of radiation after surgery or to treat the cancer. It may help doctors better understand how well this approach works and who benefits most.
This Phase 2 trial tests a type of focused radiation (stereotactic radiosurgery, or SRS) for people with small cell lung cancer that has spread to the brain. It looks at whether this approach can treat brain metastases when the cancer has limited to a certain number of spots.
This trial tests a special type of radiation therapy for brain tumors that aims to protect your memory and thinking skills. It may be an option if you have certain brain tumors or a small number of brain metastases.
This trial compares two types of radiation for people with small cell lung cancer that has spread to the brain (10 or fewer spots). One approach uses focused radiation only on the tumors, the other treats the whole brain while trying to protect memory. The goal is to see which works better with fewer side effects.
This study tests a more targeted form of stereotactic (precise) brain radiation for people with brain metastases from large cell cancer. It aims to improve the balance between effectiveness and side effects by carefully focusing where the radiation goes.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
Hear when a new Brain Metastases, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.